Info
Collaborating to the Success of Pfizer‘s Brands in Oncology.
My objective is to…
Aktivitäten
-
It was a great pleasure to host a panel discussion on longevity at the HSG Community Festival with our HSG Alumni Healthcare & Life Sciences Club. A…
It was a great pleasure to host a panel discussion on longevity at the HSG Community Festival with our HSG Alumni Healthcare & Life Sciences Club. A…
Beliebt bei Ari Heer
-
Les cancers rares touchent peu de personnes individuellement… ... mais ensemble, ils représentent près d’un quart des nouveaux cas de cancer. Un…
Les cancers rares touchent peu de personnes individuellement… ... mais ensemble, ils représentent près d’un quart des nouveaux cas de cancer. Un…
Beliebt bei Ari Heer
-
🇨🇭 From first-year learners to soon-to-be graduates — our five apprentices are growing, thriving, and making us proud every day 💙 Over the course…
🇨🇭 From first-year learners to soon-to-be graduates — our five apprentices are growing, thriving, and making us proud every day 💙 Over the course…
Beliebt bei Ari Heer
Berufserfahrung
-
-
-
-
-
-
-
-
-
Ausbildung
-
-
-
–
-
-
–
Bescheinigungen und Zertifikate
Weitere Aktivitäten von Ari Heer
-
Je suis expert pour les examens oraux de « Spécialiste pharmaceutique avec brevet fédéral » de la @swisshealthqualityassociation. Lorsque l'on est…
Je suis expert pour les examens oraux de « Spécialiste pharmaceutique avec brevet fédéral » de la @swisshealthqualityassociation. Lorsque l'on est…
Beliebt bei Ari Heer
-
💙 Ακόμη και μέσα στις πιο δύσκολες στιγμές, μπορούμε να βρούμε φως Ευχαριστώ θερμά τη Φιλίππα Ταμπάρη @filippatampari και την πολιτική εφημερίδα…
💙 Ακόμη και μέσα στις πιο δύσκολες στιγμές, μπορούμε να βρούμε φως Ευχαριστώ θερμά τη Φιλίππα Ταμπάρη @filippatampari και την πολιτική εφημερίδα…
Beliebt bei Ari Heer
-
Whether you work in USA 🇺🇸, Switzerland 🇨🇭, Sweden 🇸🇪 or Greece🇬🇷, it doesn’t matter, Greek Oncology rocks!!! 🎸🚀 United by life-long…
Whether you work in USA 🇺🇸, Switzerland 🇨🇭, Sweden 🇸🇪 or Greece🇬🇷, it doesn’t matter, Greek Oncology rocks!!! 🎸🚀 United by life-long…
Beliebt bei Ari Heer
-
Did you miss our latest newsletter? 📬 We highlighted the #ISTs Innovation Forum, held during WCLC in Barcelona—a key event that brought together…
Did you miss our latest newsletter? 📬 We highlighted the #ISTs Innovation Forum, held during WCLC in Barcelona—a key event that brought together…
Beliebt bei Ari Heer
-
On Sunday, I ran my very first half-marathon and one thing I learned: follow your own rhythm. We all have our own pace and our own way of achieving…
On Sunday, I ran my very first half-marathon and one thing I learned: follow your own rhythm. We all have our own pace and our own way of achieving…
Beliebt bei Ari Heer
-
🇬🇧 @National Museum of Scotland, #Edinburgh 🏛️ Ένα μουσείο που σε ταξιδεύει μέσα από την ιστορία, την επιστήμη, τη φύση και την τεχνολογία, από…
🇬🇧 @National Museum of Scotland, #Edinburgh 🏛️ Ένα μουσείο που σε ταξιδεύει μέσα από την ιστορία, την επιστήμη, τη φύση και την τεχνολογία, από…
Beliebt bei Ari Heer
-
The results are in 🗳️ During ILCS 2025, Dr. Stephanie Saw asked our audience which 1L treatment they would prefer for HER2-mutated NSCLC if…
The results are in 🗳️ During ILCS 2025, Dr. Stephanie Saw asked our audience which 1L treatment they would prefer for HER2-mutated NSCLC if…
Beliebt bei Ari Heer
-
I’m still reflecting on the buzzing #ESMO25 last week. The place where science meets practice, where forces join to drive Innovation in oncology…
I’m still reflecting on the buzzing #ESMO25 last week. The place where science meets practice, where forces join to drive Innovation in oncology…
Beliebt bei Ari Heer
-
[6ᵉ colloque de Rhumato-Immuno-Allergologie – 9 octobre 2025] Un immense merci à tous les participants et intervenants qui ont contribué au succès…
[6ᵉ colloque de Rhumato-Immuno-Allergologie – 9 octobre 2025] Un immense merci à tous les participants et intervenants qui ont contribué au succès…
Beliebt bei Ari Heer
-
[Pink Pony Walk] 🩷Dans le cadre d’Octobre Rose, Ralph Lauren organise chaque année à travers le monde des initiatives solidaires sous la bannière…
[Pink Pony Walk] 🩷Dans le cadre d’Octobre Rose, Ralph Lauren organise chaque année à travers le monde des initiatives solidaires sous la bannière…
Beliebt bei Ari Heer
-
Bravo à la Pre Abdulcadir Jasmine, médecin adjointe au Service de gynécologie et professeure assistante au Département de pédiatrie, gynécologie et…
Bravo à la Pre Abdulcadir Jasmine, médecin adjointe au Service de gynécologie et professeure assistante au Département de pédiatrie, gynécologie et…
Beliebt bei Ari Heer
Weitere ähnliche Profile
Weitere Beiträge entdecken
-
Fresenius Kabi
A new chapter in our #Biosimilars journey: Fresenius has received European Commission approval for its denosumab biosimilars, covering all indications of the reference medicines. This enables more patients across Europe to have access to high-quality, affordable treatment options for serious bone conditions – a significant milestone of our biosimilars business. As part of Fresenius, Fresenius Kabi continues to contribute to better care for patients and advancing the goals of #FutureFresenius. 👉 Read the full media release here: https://lnkd.in/eBfq6zV7 #Biopharma #CommittedToLife
41 Kommentare -
BlueRock Therapeutics
Together with Bayer | Pharmaceuticals, BlueRock announced positive 36-month data from our Phase I clinical trial for our investigational cell therapy for the treatment of Parkinson's disease. The data were presented on yesterday at the International Congress of Parkinson’s Disease and Movements Disorders. Read the full release: https://lnkd.in/eEqQiQQ4
15 Kommentare -
Arbor Biotechnologies
We're thrilled to announce a strategic collaboration with Chiesi Global Rare Diseases to advance the continued development of ABO-101 for the treatment of primary hyperoxaluria type 1 (PH1) as well as gene editing programs targeting additional rare liver diseases. This partnership combines our deep expertise in gene editing and early therapeutic development with Chiesi’s proven track record of bringing innovative rare disease therapies to patients worldwide. Together, we’re committed to delivering transformative treatments for people living with rare diseases. Learn more about the partnership: https://lnkd.in/ej7vKTwE #PH1 #RareDisease #GeneEditing #Biotech #Innovation
7 Kommentare -
EURORDIS-Rare Diseases Europe
In a recent interview with France Culture, Virginie HIVERT, Acting Chief Executive Officer and Head of Therapies & Access at EURORDIS, highlighted the growing importance of drug repurposing to address the unmet needs of people living with rare diseases. With thousands of rare diseases, many extremely rare and heterogeneous - the incentive to develop entirely new treatments is often limited, making repurposing a vital strategy. Virginie explains that repurposing can apply to medicines already on the market, where safety profiles are well known, but further research is still needed to demonstrate efficacy in rare disease contexts. 🗣️ “Repositioning can concern medicines that are already on the market - in this case, we already know their safety profile. But to move forward, it’s essential to truly demonstrate their effectiveness for the rare disease at stake.” - Virginie Hivert 🎧 You can listen to the full interview (in French) : https://lnkd.in/ehwdQrfM
1 Kommentar